Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2025-12-25 @ 9:47 PM
NCT ID:
NCT04034251
Group ID:
EG000
Title:
Paclitaxel Intraperitoneal 20mg & Intravenous 80mg Every 3Weeks & Capecitabine 825mg/m^2 Twice Daily
Description:
Intraperitoneal and intravenous paclitaxel administration with concomitant oral capecitabine.
Intraperitoneal Paclitaxel (20 mg/m\^2) every 3 weeks (Q3WK), intravenous Paclitaxel (80 mg/m\^2) Q3WK, Capecitabine (825mg/m\^2 twice daily (BID) x 14 days of each cycle).
Cohort A: Participants with confirmed diagnosis of gastric adenocarcinoma or gastroesophageal junction (Siewert III) adenocarcinoma who have received prior systemic chemotherapy.
Deaths Number Affected:
4
Deaths Number At Risk:
None
Serious Number Affected:
1
Serious Number At Risk:
4
Other Number Affected:
4
Other Number At Risk:
4
Study:
NCT04034251
Results Section:
NCT04034251
Adverse Events Module:
NCT04034251